Cargando…
Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis
Uncontrolled massive bleeding with subsequent derangement of the coagulation system is a major challenge in the management of both surgical and seriously injured patients. Under physiological conditions activators and inhibitors of coagulation regulate the sensitive balance between clot formation an...
Autores principales: | Pabinger, Ingrid, Fries, Dietmar, Schöchl, Herbert, Streif, Werner, Toller, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429347/ https://www.ncbi.nlm.nih.gov/pubmed/28432428 http://dx.doi.org/10.1007/s00508-017-1194-y |
Ejemplares similares
-
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
por: Gremmel, Thomas, et al.
Publicado: (2018) -
Management of dabigatran-induced bleeding: expert statement
por: Fries, Dietmar, et al.
Publicado: (2013) -
Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia
por: Ilich, Anton, et al.
Publicado: (2022) -
Conventional and Pro-Inflammatory Pathways of Fibrinolytic Activation in Non-Traumatic Hyperfibrinolysis
por: Zipperle, Johannes, et al.
Publicado: (2022) -
Perioperative hyperfibrinolysis – physiology and pathophysiology
por: Marinho, David Silveira
Publicado: (2020)